Advanced Therapeutics

SCIE

國(guó)際簡(jiǎn)稱：Advanced Therapeutics 參考譯名：先進(jìn)治療學(xué)

主要研究方向：Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science 非預(yù)警期刊審稿周期：

《先進(jìn)治療學(xué)》(Advanced Therapeutics)是一本由Wiley-Blackwell出版的以Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

4區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
162 年發(fā)文量
3.7 IF影響因子
未開(kāi)放 是否OA
English 出版語(yǔ)言

Advanced Therapeutics provides a unique multidisciplinary forum for the best research in the next generation of therapeutics, such as targeted drug delivery, cellular and genetic therapies, personalized medicines and theranostics, as well as pharmacology, toxicology and drug discovery.Intended to provide a platform for researchers worldwide to exchange and share the latest research findings. As a professional journal dedicated to the field of therapeutic medicine, we are committed to promoting the development of medical scientific research, improving the treatment effectiveness of diseases, and contributing to human health and well-being.

[ 查看全部 ]

投稿咨詢加急咨詢

Advanced Therapeutics期刊信息

ISSN：2366-3987
出版語(yǔ)言：English
是否OA：未開(kāi)放
E-ISSN：2366-3987
出版地區(qū)：GERMANY
是否預(yù)警：否
出版商：Wiley-Blackwell
開(kāi)源占比：0.1786
Gold OA文章占比：25.95%
OA被引用占比：
出版國(guó)人文章占比：0.26
出版撤稿占比：
研究類文章占比：67.90%

Advanced Therapeutics CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.1

1.063

0.655

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Medicine (miscellaneous)	Q1	65 / 398	83%
大類：Medicine 小類：Pharmacology (medical)	Q1	54 / 272	80%
大類：Medicine 小類：Pharmaceutical Science	Q1	38 / 183	79%
大類：Medicine 小類：Genetics (clinical)	Q1	24 / 99	76%
大類：Medicine 小類：Biochemistry (medical)	Q2	19 / 72	74%
大類：Medicine 小類：Pharmacology	Q2	89 / 313	71%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。

Advanced Therapeutics中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū)

Advanced Therapeutics JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	90 / 354	74.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q1	84 / 354	76.41%

Advanced Therapeutics歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Advanced Therapeutics中國(guó)學(xué)者發(fā)文選摘

1、TBX2-WNT3A Axis Mediates the Development of Colorectal Cancer In Vitro and In Vivo
Author: Zhou, Yan; Dong, Mingjie; Li, Xiujuan

Journal: ADVANCED THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/adtp.202200306
2、Second Near-Infrared Light Triggered Mini Plasmonic Heterostructures for Photothermal-Derived Multimodal Synergistic Cancer Therapy
Author: Xu, Zhourui; Aalinkeel, Ravikumar; Mahajan, Supriya D.; Rao, Nanxi; Chen, Ting; Jiang, Yihang; Yang, Chengbin; Xu, Gaixia; Schwartz, Stanley A.; Law, Wing-Cheung

Journal: ADVANCED THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/adtp.202200248
3、Enhanced Targeting, Retention, and Penetration of Amphotericin B Through a Biomimetic Strategy to Treat Against Vulvovaginal Candidiasis
Author: Lin, Yijing; Yin, Qingqing; Zhuge, Deli; Hu, Yiqin; Yang, Xuewei; Tian, Dongyan; Li, Li; Wang, Haonan; Liu, Shuangshuang; Weng, Cuiye; Zhang, Xufei; Wen, Bin; Wang, Fang; Yan, Linzhi; Chen, Mengchun; Wang, Ledan; Chen, Yijie

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 1, pp. -. DOI: 10.1002/adtp.202200086
4、Multifunctional Alendronate-PEI Carbon Dots for the Treatment of Bone-Destructive Diseases via Bidirectional Regulation of Osteoblast-Osteoclast Function
Author: Zhang, Kai; Da, Junlong; Wang, Jianqun; Liu, Lixue; Liu, Xinpeng; Yuan, Haoze; Jiang, Lili; Geng, Yawei; Liu, Xiaoyao; Jiang, Zhuling; Jin, Han; Li, Ying; Zhang, Bin

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 2, pp. -. DOI: 10.1002/adtp.202200149
5、Bio-Inspired Coordination-Assembled Nanoparticles for Enhanced Drug Delivery of Tumor Chemotherapeutics
Author: Lu, Ruojing; Shi, Xiubo; Pan, Yao; Li, Jinheng; Liu, Zhiwei; Xiao, Qian; Wang, Xuejiao; Chen, Jianping; Zhang, Xingmei; Meng, Jingxin; Zhao, Wei; Wang, Ying; Fan, Jun-Bing

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 1, pp. -. DOI: 10.1002/adtp.202200131
6、Fructose-Coated Angstrom Silver Particles Suppress Gastric Cancer Growth by Activating Gasdermin D-Mediated Pyroptosis
Author: Li, You-You; Xia, Kun; Liu, Yi-Wei; Tan, Yi-Juan; Li, Hong-Ming; Wang, Yi-Yi; Feng, Shi-Kai; Jin, Ling; Wan, Teng-Fei; Cao, Jia; Chen, Chun-Yuan; Liu, Zheng-Zhao; Hu, Xiong-Ke; Wu, Ben; Wang, Yang; He, Ze-Hui; Yin, Hao; Situ, Wei-Yi; Qi, Lu-Yue; Wang, Zhen-Xing; Xie, Hui

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 1, pp. -. DOI: 10.1002/adtp.202200100
7、Targeted and Infarcted Microenvironment-Responsive Peptide Therapeutics to Reverse Cardiac Remodeling
Author: Qin, Yu-Yan; Li, Songpei; Qin, Aiping; Lin, Yinshan; Ye, Jinxian; Huang, Yingying; Wang, Jianglin; Liang, Lu; Yu, Xi-Yong; Zhang, Lingmin

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 2, pp. -. DOI: 10.1002/adtp.202200121
8、Persistent and Enhanced Elimination of Bacteria-Induced Periodontitis Using a Local Drug Delivery Nanoreactor
Author: Xu, Lihua; Chen, Shileng; Feng, Yushuo; Chen, Ming; Liu, Yaqing; Ma, Xiaoqian; Jing, Jinpeng; Meng, Shanshan; Yao, Youliang; Sun, Wenjing; Chen, Hongmin

Journal: ADVANCED THERAPEUTICS. 2023; Vol. 6, Issue 2, pp. -. DOI: 10.1002/adtp.202200230